Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
lock up 100% of shares folks.
you are going to be very rich. lock up 100% of shares and then just keep adding all you can afford.
I think we are going to become an acquisition candidate far sooner than I expected.
that is one of the reason for this climb into the outer space.
it is only the beginning.
the best is yet to come.
your shares will be in very high demand. lock them up.
this will hit $5 the second we hit production in april.
we have more licensing deals on the way for our sublingual tablet.
and you are looking at $10 or better at the end of 2017.
OWCP is a very big deal. this is your next gwph.
anything and everything under 90 cents is a steal.
stock is still undervalued.
float is locked up.
awesome looking chart.
most of the limited float is now locked up.
this could really head to the stars.
there is no slowing down OWCP now.
it is going to run over anything and everything.
shorts are going to be burned alive.
short squeeze will push this past 70 cents today.
awesome 8-k. it is very reassuring.
all systems are go now. we are headed into the outer space territory.
anything and everything under 80 cents is a bloody steal now.
we are going to start racing towards 70 cents.
hell at the rate even 70 cents is ancient history.
this is absolutely huge.
our sublingual tablet incorporates a unique delivery system which we invented. it is protected.
you can make that 70 cents now mate.
stock will start racing towards 70 cents today.
I am probably wrong when I say we are north of 80 cents at the close on Thursday.
it may even be north of 90 cents at the close on Thursday.
momentum is out of this world.
right now and at the current rate anything and everything under 80 cents is a steal.
that is where it is going to be soon. I would say that at the close on Thursday this stock is north of 80 cents.
stock is eying dollars and there is nothing that can be done to slow it down.
All OWCP research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
Israel is considered one of the best places in the world for cannabis research. According to The Cannabist, “Unlike the U.S. government, the Israeli government has had few restrictions on doing research on cannabis, whether basic science or clinical studies.” OWCP says that its research division “leverages the Company’s extensive network comprising some of Israel’s leading researchers, scientists, universities and hospitals, as well as cannabis breeders and extractors, to study and test the effectiveness of different combinations of cannabinoids in the treatment of disease and chronic conditions.”
To date, OWCP has signed three research collaboration and license agreements with Sheba Academic Medical Center, Tel Hashomer, Israel. Sheba is a university-affiliated hospital that serves as Israel’s national medical center and the most comprehensive medical center in the Middle East. Within the framework of the agreements with Sheba, OWCP will initiate three studies at the Sheba facilities to explore the effect of three formulations, all based on active ingredients in the cannabis extracts, on multiple myeloma, psoriasis and fibromyalgia (a specific formulation to each indication).
The Company has also signed a Memorandum of Understanding with Emilia Cosmetics Ltd., a large Israeli private label manufacturer, for the development, manufacture and marketing of a cannabinoid-based topical cream to treat psoriasis. The Company will initiate the development of the topical cream at Emilia Cosmetics labs located in Yerucham, Israel. After the completion of the formulation development, the Company will initiate a phase I study at the Sheba facilities to explore the effect of topical cream on psoriasis.
In October, OWCP completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the Tablet is protected and provides for the ingestion of virtually any dosage of medical cannabis with a sublingual delivery mechanism, whereby the compounds are absorbed directly into the patient’s blood through oral epithelial tissue. The Tablet also enables physicians to safely and accurately monitor the dosage and treatment of each individual patient, something that is essentially impossible to do for patients who administer cannabis by smoking.
OWCP is working towards having the Tablet approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use within the country’s sanctioned medical cannabis program, as well as talking with potential licensees of the technology in the United States. Longer term, management expects to establish clinical tests of the Tablet in protocols for Multiple Myeloma, Post-Traumatic Stress Disorder (PTSD), and Fibromyalgia.
this stock is so ready to head into the outer space where there is absolutely no slowing it down.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is following the game plan we laid out for our subscribers back in November. We said that the stock was going to consolidate before heading higher. Shares have done just that and made new 52 week highs. OWCP is now up almost 8000% in the past year.
What’s most surprising is that even with the current gains, OWCP sports a market cap of just $33 million. When you consider that Medical Marijuana Inc (OTCMKTS:MJNA) has a $520 million market cap, Cannabis Sativa Inc (OTCMKTS:CBDS) a $119 million market cap, or Cannabis Science Inc (OTCMKTS:CBIS) a $157 million market cap, it’s easy to make the case OWCP remains undervalued compared to its peers. Furthermore, there are a number of upcoming catalysts that we believe can keep OWCP on its upward trajectory.
OWC Pharmaceutical Research Corp. (OTCQB: OWCP) engages in the research and development of Cannabis-based medical products. OWCP provides medical products for the treatment of various medical conditions and/or diseases, and provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. OWC Pharmaceutical conducts medical research and clinical trials through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, PTSD, migraines, and of a unique delivery system
short squeeze could push this to 70 cents later today.
once we hit around 67 cents later today, 60 cents will be gone forever.
I think this just might make a run to 70 cents.
momentum is out of this world.
100% of my shares are locked up.
and I am adding more each and every week.
this is fixing to skyrocket and leave a lot of people behind.
OWCP is making rapid progress.
no shortage of catalysts. this is where you step in and add/accumulate more.
OWCP is an opportunity of a lifetime.
think of this as the little correction and the consolidation as we race towards 63 cents shortly.
desperate shorts trying to look for weak legs and cowards.
but for each weak leg running to the hill, there are 50 trying to get in.
for each one selling, there are 50 looking to get in fast at these bargain prices.
it did not take long for them to try to manipulate it.
shorts are going to get smoked.
there is massive pent up demand for this stock.
people want in.
smart investors will snatch all they can fast under 60 cents while they can.
60 cents is ancient history after this morning.
excellent post.
this stock is going to skyrocket and leave a lot of people behind in the dust.
did anybody see the 8-k?
this is going to run hard.
it is going to run right over the shorts and the flippers.
distributions agreements are in place to not only take our products to medical cannabis markets rapidly in America but all also all over the world.
too many catalysts in play.
OWCP is a very big deal.
it could happen.
stock has incredible momentum that will carry over into tomorrow.
much obliged for the kind remarks.
OWCP is pure excitement.
this is my kind of company. I am going to stay with them forever.
OWCP is working towards having the Tablet approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use within the country’s sanctioned medical cannabis program, as well as talking with potential licensees of the technology in the United States. Longer term, management expects to establish clinical tests of the Tablet in protocols for Multiple Myeloma, Post-Traumatic Stress Disorder (PTSD), and Fibromyalgia.
I am being reasonable but we all know that OWCP is the next gwph.
this stock is going to change lives here.
you just have to accumulate the hell out it and you have keep accumulating it.
the second we hit production april, OWCP is likely to hit $5.
OWCP is a very big deal.
Currently trading with a market cap of $33 million, there are presently 139 million shares outstanding and 86 million shares in the float. We are expecting news from the company any day now regarding its Tablet and/or its psoriasis topical cream. Either one will have the shorts scrambling and keep OWCP making new highs. In light of its low market cap compared to its peers, OWCP looks to be a must-own for cannabis investors.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is following the game plan we laid out for our subscribers back in November. We said that the stock was going to consolidate before heading higher. Shares have done just that and made new 52 week highs. OWCP is now up almost 8000% in the past year.
What’s most surprising is that even with the current gains, OWCP sports a market cap of just $33 million. When you consider that Medical Marijuana Inc (OTCMKTS:MJNA) has a $520 million market cap, Cannabis Sativa Inc (OTCMKTS:CBDS) a $119 million market cap, or Cannabis Science Inc (OTCMKTS:CBIS) a $157 million market cap, it’s easy to make the case OWCP remains undervalued compared to its peers. Furthermore, there are a number of upcoming catalysts that we believe can keep OWCP on its upward trajectory.
First up, a little background on the company. OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWCP is also developing unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWCP research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
Israel is considered one of the best places in the world for cannabis research. According to The Cannabist, “Unlike the U.S. government, the Israeli government has had few restrictions on doing research on cannabis, whether basic science or clinical studies.” OWCP says that its research division “leverages the Company’s extensive network comprising some of Israel’s leading researchers, scientists, universities and hospitals, as well as cannabis breeders and extractors, to study and test the effectiveness of different combinations of cannabinoids in the treatment of disease and chronic conditions.”
To date, OWCP has signed three research collaboration and license agreements with Sheba Academic Medical Center, Tel Hashomer, Israel. Sheba is a university-affiliated hospital that serves as Israel’s national medical center and the most comprehensive medical center in the Middle East. Within the framework of the agreements with Sheba, OWCP will initiate three studies at the Sheba facilities to explore the effect of three formulations, all based on active ingredients in the cannabis extracts, on multiple myeloma, psoriasis and fibromyalgia (a specific formulation to each indication).
The Company has also signed a Memorandum of Understanding with Emilia Cosmetics Ltd., a large Israeli private label manufacturer, for the development, manufacture and marketing of a cannabinoid-based topical cream to treat psoriasis. The Company will initiate the development of the topical cream at Emilia Cosmetics labs located in Yerucham, Israel. After the completion of the formulation development, the Company will initiate a phase I study at the Sheba facilities to explore the effect of topical cream on psoriasis.
In October, OWCP completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the Tablet is protected and provides for the ingestion of virtually any dosage of medical cannabis with a sublingual delivery mechanism, whereby the compounds are absorbed directly into the patient’s blood through oral epithelial tissue. The Tablet also enables physicians to safely and accurately monitor the dosage and treatment of each individual patient, something that is essentially impossible to do for patients who administer cannabis by smoking.
OWCP is working towards having the Tablet approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use within the country’s sanctioned medical cannabis program, as well as talking with potential licensees of the technology in the United States. Longer term, management expects to establish clinical tests of the Tablet in protocols for Multiple Myeloma, Post-Traumatic Stress Disorder (PTSD), and Fibromyalgia.
OWCP is going to run hard tomorrow.
momentum here is off the charts.
there is huge pent up demand for this stock.
people want in.
https://www.insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-on-a-bull-run/118980/
for each one willing or looking to sell, there are at least 40 that are looking to snatch up cheaper shares.
nobody gives a damn if anybody sells.
go ahead and sell.
sell until your heart is content.
stock is going to run hard tomorrow.
it is going to run right over shorts and small time flippers.
momentum is sensational here. it is going to carry over to tomorrow.
Get your cash ready for tomorrow morning.
Window to snatch shares under 60 cents could be very brief and short lived.
Short squeeze could push this closer to 70 cents tomorrow at the close.
You will be looking at 80 cents to 90 cents on Friday.
With current momentum it may even approach $1 at the close on friday.
It is going to run hard tomorrow.
OWCP is a very big deal.
Accumulate the hell out of this stock.
OWCP could hit $1 and it may even run past $1 on Friday at the close.
that is the trajectory.
also company could drop a very big hammer on Thursday after the close.
trajectory is north.
momentum is staggering.
there is huge pent up demand for this stock.
people want in.
this stock is headed to around $2.20 to $2.35.
so that is where we can expect some correction but the trajectory here is north.
way too may catalysts
way too many developments taking place
company is making rapid progress
***there is just no reason for to slow down when you also consider other variables: it is still deeply undervalued.
great video.
I have been adding forever.
I add/accumulate each and every week all I can afford.
I think 60 cents is ancient history after Tuesday morning.
it is going to run hard.
we will just have to see how it plays out. close on Tuesday could be anywhere from 63 cents to near 70 cents with the short squeeze.
I invested in the company.
I believe in OWCP.
OWCP buyout will take it to $20 to $30 overnight.
goldman sachs has handed out an acquisition value of $349 a share for gwph.
it is simply too risky to not own a ton of this stock.
even without the buyout you are looking at $7 to $10 at the end of 2017.
lock up 100% of your shares.
don't even let them see daylight.
and add/accumulate all you can afford.
destroy the shorts and the flippers. run right over them.
lets take this to $2 fast.
plenty of catalysts in play now at OWCP.
trajectory is north and there is nothing that can be done to stop it.
this is the next gwph.
we may even hit 70 cents on Tuesday.
don't forget that the short squeeze may push it to 70 cents on Tuesday.
it is going to run hard on Tuesday.
there is massive pent up demand for this stock.
people want in.
we are very lucky to have got in at the ground floor.
growth potential for OWCP is off the charts.
Teva has already invested millions to get into medical cannabis.
they have very deep pockets.
they could be one of the large companies to snatch up OWCP.
it may gap up on Tuesday.
and then look for a very minor dip. it will be very short lived.
for each one wanting to sell, there will be 30 investors looking to buy.
chances to grab this under 60 cents will start to diminish on Tuesday.
it is an absolute steal under 80 cents.
great post.
re-post this for our newcomers tomorrow evening also.
OWCP is deeply undervalued.
it is going to continue to rise.